Clinical Trial Update: User Evaluation Study of SyncVision System With Software v4.X

View source ↗

Summary

A user evaluation study of the SyncVision System with software version 4.X for coronary artery disease has been terminated. The sponsor is Volcano Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Volcano Corporation | Conditions: Coronary Artery Disease | Status: TERMINATED